Knowledge, beliefs and attitudes of physicians in low and middle-income countries regarding interacting with pharmaceutical companies: A systematic review

BMC Health Services Research

Volumn 16, Issue 1, 2016, Pages

  Lotfi, Tamara ^a   Morsi, Rami Z ^a   Rajabbik, Mhd Hashem ^a   Alkhaled, Lina ^a   Kahale, Lara ^a   Nass, Hala ^b   Brax, Hneine ^c   Fadlallah, Racha ^a   Akl, Elie A ^a,d  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b DAMASCUS UNIVERSITY   (Syrian Arab Republic)

^c SAINT JOSEPH UNIVERSITY   (Lebanon)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Attitudes; Beliefs; Knowledge; Pharmaceutical company representatives; Physicians

Indexed keywords

ATTITUDE TO HEALTH; DEVELOPING COUNTRY; DRUG INDUSTRY; GENERAL PRACTITIONER; HEALTH PERSONNEL ATTITUDE; HUMAN; INCOME; MALE; MEDICAL EDUCATION; PHARMACIST; PHYSICIAN; PRESCRIPTION; PUBLIC RELATIONS; REWARD;

ATTITUDE OF HEALTH PERSONNEL; DEVELOPING COUNTRIES; DRUG INDUSTRY; EDUCATION, MEDICAL, CONTINUING; GENERAL PRACTITIONERS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INCOME; INTERPROFESSIONAL RELATIONS; MALE; PHARMACISTS; PHYSICIANS; PRESCRIPTIONS; REWARD;

EID: 84958190932     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/s12913-016-1299-4     Document Type: Article

References (26)

1. Greene JA. Pharmaceutical marketing research and the prescribing physician. Ann Intern Med. 2007;146(10):742-8.
2. Adeoye S, Bozic KJ. Direct to consumer advertising in healthcare: history, benefits, and concerns. Clin Orthop Relat Res. 2007;457:96-104.
3. Campbell EG et al. Physician professionalism and changes in physician-industry relationships from 2004 to 2009. Arch Intern Med. 2010;170(20):1820-6.
4. ACCME. Accreditation Council for Continuing Medical Education annual report data. 2006.
5. MA Alssageer, SR Kowalski, Doctors' opinions of information provided by Libyan pharmaceutical company representatives. Libyan J Med. 2012. 7(1).
6. Guldal D, Semin S. The influences of drug companies' advertising programs on physicians. Int J Health Serv. 2000;30(3):585-95.
7. Rosenthal, Meredith B., et al. "Demand effects of recent changes in prescription drug promotion." Forum for Health Economics & Policy. 2003;6:1.
8. Iizuka T, Jin GZ. The Effect of Prescription Drug Advertising on Doctor Visits. J Econ Manag Strategy. 2005;14(3):701-27.
9. Spurling GK et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLoS Med. 2010;7(10):e1000352.
10. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283(3):373-80.
11. Morgan M et al. Interactions of doctors with the pharmaceutical industry. J Med Ethics. 2006;32(10):559-63.
12. Rutledge P et al. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey. Pharmacoepidemiol Drug Saf. 2003;12(8):663-7.
13. Underwood C. Belief and attitude change in the context of human development, Sustainable Human Development, from Encyclopedia of Life Support Systems (EOLSS), Developed under the Auspices of the UNESCO. Oxford, UK: Eolss Publishers; 2002. http://www.eolss.net/sample-chapters/c11/e6-60-03-07.pdf.
14. Al-Areefi MA, Hassali MA, Ibrahim MI. Physicians' perceptions of medical representative visits in Yemen: a qualitative study. BMC Health Serv Res. 2013;13:331.
15. Al-Areefi MA, Hassali MA, Mohamed Ibrahim MI. The role of pharmaceutical marketing and other factors in prescribing decisions: the Yemeni experience. Res Social Adm Pharm. 2013;9(6):981-8.
16. Alssageer MA, Kowalski SR. What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives? Pan Afr Med J. 2013;14:132.
17. Oshikoya KA, Oreagba I, Adeyemi O. Sources of drug information and their influence on the prescribing behaviour of doctors in a teaching hospital in Ibadan, Nigeria. Pan Afr Med J. 2011;9(1):13.
18. MSV R et al. Information Seeking Behaviour Of Clinicians In a Semi Urban Town In Southern India. J Clin Diagn Res. 2008;2:1069-73.
19. Siddiqi A. Relevant influence of promotional tools by pharmaceutical industry on prescribing behaviors of doctors: A cross-sectional survey in Pakistan. Afr J Pharm Pharmacol. 2011;5(13):1623-32.
20. Loh L, Ong H, Quah S. Impact of various continuing medical education activities on clinical practice-a survey of Malaysian doctors on its perceived importance. Ann-Acad Med Singapore. 2007;36(4):281.
21. Mikhael EM et al. The reliabilty and accuracy of medical and pharmaceutical information that were given by drug companies through medical representatives to iraqi physicians. Int J Pharm Pharm Sci. 2014;45:8.89.
22. Scheffer MC. Interaction between pharmaceutical companies and physicians who prescribe antiretroviral drugs for treating AIDS. Sao Paulo Med J. 2014;132(1):55-60.
23. Austad KE, Avorn J, Kesselheim AS. Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic review. PLoS Med. 2011;8(5):e1001037.
24. Lieb K, Scheurich A. Contact between Doctors and the Pharmaceutical Industry, Their Perceptions, and the Effects on Prescribing Habits. PLoS One. 2014;9(10):e110130.
25. Castresana L. ACTITUD DE LOS MEDICOS FRENTE A LAS PRACTICAS DE PROMOCION DE LA INDUSTRIA FARMACEUTICA. Medicina (Buenos Aires). 2005;65(3):247-51.
26. Alkhaled L et al. Legislative, educational, policy and other interventions targeting physicians' interaction with pharmaceutical companies: a systematic review. BMJ Open. 2014;4(7):e004880.